Evidence map›Paper›PMID 20550965›Full record

ArticleBiochimica et biophysica acta2010

Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia.

Stephen J Harding, Gareth J Browne, Bryan W Miller, Sally A Prigent, Martin Dickens

Open access · hybridAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Effects of propofol on hippocampal neuron viability.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  3. Long non-coding RNA-ROR aggravates myocardial ischemia/reperfusion injury.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2018
    Article
  4. Article
  5. Article
  6. Ischemia/Reperfusion.Comprehensive Physiology · 2016
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cell biology of ischemia/reperfusion injury.International review of cell and molecular biology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stephen J HardingDepartment of Biochemistry, Henry Wellcome Building, University of Leicester, Leicester, UK.
Gareth J Browne
Bryan W Miller
Sally A Prigent
Martin Dickens
University of Leicester · GB

Funding

British Heart Foundation
6 · The paper itself

Abstract

p38 MAPK is activated potently during cardiac ischaemia, although the precise mechanism by which it is activated is unclear. We used the isolated perfused rat heart to investigate the signalling pathways activated upstream of p38 during global cardiac ischaemia. Ischaemia strongly activated p38alpha but not the JNK pathway. The MAPKKs, MKK3, MKK4 and MKK6 have previously been identified as potential upstream activators of p38; however, in the ischaemic perfused heart, we saw activation of MKK3 and MKK6 but not MKK4. MKK3 and MKK6 showed different temporal patterns of activity, indicating distinct modes of activation and physiological function. Consistent with a lack of JNK activation, we saw no activation of MKK4 or MKK7 at any time point during ischaemia. A lack of MKK4 activation indicates, at least in the ischaemic heart, that MKK4 is not a physiologically relevant activator of p38. The MAPKKK, ASK1, was strongly activated late during ischaemia, with a similar time course to that of MKK6 and in ischaemic neonatal cardiac myocytes ASK1 expression preferentially activated MKK6 rather than MKK3. These observations suggest that during ischaemia ASK1 is coupled to p38 activation primarily via MKK6. Potent activation of ASK1 during ischaemia without JNK activation shows that during cardiac ischaemia, ASK1 preferentially activates the p38 pathway. These results demonstrate a specificity of responses seldom seen in previous studies and illustrate the benefits of using direct assays in intact tissues responding to physiologically relevant stimuli to unravel the complexities of MAPK signalling.

Indexed as

AnimalsAnimals, NewbornCells, CulturedEnzyme ActivationExtracellular Signal-Regulated MAP KinasesHumansIsoenzymesMaleMAP Kinase Kinase Kinase 5MAP Kinase Signaling SystemMitogen-Activated Protein Kinase KinasesModels, BiologicalMyocardial IschemiaRatsRats, Sprague-DawleyRats, WistarExtracellular Signal-Regulated MAP KinasesIsoenzymesMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinase Kinases

Identifiers

PMID20550965
PMCPMC2954285
OpenAlexW2107209079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.